The Cooper Companies Inc.

323.49+15.78+5.13%Vol 528.56K1Y Perf -21.22%
Jun 24th, 2022 16:03 DELAYED
BID297.76 ASK516.09
Open311.32 Previous Close323.49
Pre-Market- After-Market323.49
 - -  - -%
Target Price
409.50 
Analyst Rating
Strong Buy 1.50
Potential %
26.59 
Finscreener Ranking
★+     43.32
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     45.63
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★+     56.11
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
+     28.08
Price Range Ratio 52W %
15.73 
Earnings Rating
Sell
Market Cap15.96B 
Earnings Date
2nd Jun 2022
Alpha0.00 Standard Deviation0.07
Beta0.90 

Today's Price Range

308.71323.81

52W Range

297.34463.59

5 Year PE Ratio Range

25.30123.90

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
6.08%
1 Month
-4.81%
3 Months
-20.79%
6 Months
-21.33%
1 Year
-21.22%
3 Years
-1.66%
5 Years
31.40%
10 Years
311.70%

TickerPriceChg.Chg.%
COO323.4915.78005.13
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
0.60
1.10
0.27
0.50
18.90
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
65.90
16.90
27.40
15.30
27.91
RevenueValueIndustryS&P 500US Markets
3.14B
63.63
4.91
6.63
DividendsValueIndustryS&P 500US Markets
0.02
0.06
0.00
0.00
Payout ratio1.00
Earnings HistoryEstimateReportedSurprise %
Q02 20223.413.24-4.99
Q01 20223.083.245.19
Q04 20213.373.28-2.67
Q03 20213.303.413.33
Q02 20213.123.388.33
Q01 20212.773.1714.44
Q04 20203.113.161.61
Q03 20201.582.2844.30
Earnings Per EndEstimateRevision %Trend
7/2022 QR3.25-11.44Negative
10/2022 QR3.46-6.99Negative
10/2022 FY13.19-6.25Negative
10/2023 FY15.00-6.31Negative
Next Report Date-
Estimated EPS Next Report3.41
Estimates Count7
EPS Growth Next 5 Years %11.00
Volume Overview
Volume528.56K
Shares Outstanding49.34K
Shares Float43.52M
Trades Count14.28K
Dollar Volume169.32M
Avg. Volume383.05K
Avg. Weekly Volume427.88K
Avg. Monthly Volume392.89K
Avg. Quarterly Volume328.38K

The Cooper Companies Inc. (NYSE: COO) stock closed at 323.49 per share at the end of the most recent trading day (a 5.13% change compared to the prior day closing price) with a volume of 528.56K shares and market capitalization of 15.96B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 12000 people. The Cooper Companies Inc. CEO is Albert G. White.

The one-year performance of The Cooper Companies Inc. stock is -21.22%, while year-to-date (YTD) performance is -22.78%. COO stock has a five-year performance of 31.4%. Its 52-week range is between 297.34 and 463.59, which gives COO stock a 52-week price range ratio of 15.73%

The Cooper Companies Inc. currently has a PE ratio of 16.10, a price-to-book (PB) ratio of 2.15, a price-to-sale (PS) ratio of 4.79, a price to cashflow ratio of 21.80, a PEG ratio of 2.32, a ROA of 8.91%, a ROC of 10.32% and a ROE of 14.03%. The company’s profit margin is 27.91%, its EBITDA margin is 27.40%, and its revenue ttm is $3.14 Billion , which makes it $63.63 revenue per share.

Of the last four earnings reports from The Cooper Companies Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $3.41 for the next earnings report. The Cooper Companies Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for The Cooper Companies Inc. is Strong Buy (1.5), with a target price of $409.5, which is +26.59% compared to the current price. The earnings rating for The Cooper Companies Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

The Cooper Companies Inc. has a dividend yield of 0.02% with a dividend per share of $0.06 and a payout ratio of 1.00%.

The Cooper Companies Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 10.33, ATR14 : 9.92, CCI20 : -42.31, Chaikin Money Flow : 0.07, MACD : -11.18, Money Flow Index : 34.44, ROC : -6.91, RSI : 46.23, STOCH (14,3) : 51.04, STOCH RSI : 1.00, UO : 49.92, Williams %R : -48.96), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of The Cooper Companies Inc. in the last 12-months were: Agostino Ricupati (Option Excercise at a value of $1 242 267), Agostino Ricupati (Sold 5 607 shares of value $2 363 411 ), Brian G. Andrews (Option Excercise at a value of $703 829), Brian G. Andrews (Sold 4 963 shares of value $2 248 830 ), Colleen E. Jay (Option Excercise at a value of $0), Daniel G. McBride (Option Excercise at a value of $9 919 556), Daniel G. McBride (Sold 72 624 shares of value $32 690 354 ), Gary S. Petersmeyer (Option Excercise at a value of $290 466), Gary S. Petersmeyer (Sold 2 955 shares of value $1 282 206 ), Holly R. Sheffield (Option Excercise at a value of $0), Jody S. Lindell (Option Excercise at a value of $443 025), Jody S. Lindell (Sold 5 200 shares of value $2 119 647 ), Maria Rivas (Option Excercise at a value of $0), Mark J. Drury (Option Excercise at a value of $0), Robert S. Weiss (Option Excercise at a value of $2 115 969), Robert S. Weiss (Sold 13 039 shares of value $5 414 368 ), Teresa S. Madden (Option Excercise at a value of $0), William A. Kozy (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
9 (75.00 %)
9 (75.00 %)
8 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (25.00 %)
3 (25.00 %)
2 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.40

The Cooper Companies Inc.

Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second-largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.

CEO: Albert G. White

Telephone: +1 925 460-3600

Address: 6101 Bollinger Canyon Road, San Ramon 94583, CA, US

Number of employees: 12 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

61%39%

Bearish Bullish

62%38%

Bearish Bullish

60%40%

TipRanks News for COO

Mon, 20 Jun 2022 02:05 GMT Cooper Co (COO) Receives a Buy from Stifel Nicolaus

- TipRanks. All rights reserved.

Fri, 03 Jun 2022 11:45 GMT Analysts Conflicted on These Healthcare Names: Cooper Co (COO) and Centessa Pharmaceuticals (CNTA)

- TipRanks. All rights reserved.

Wed, 01 Jun 2022 12:05 GMT Cooper Co (COO) Receives a Hold from J.P. Morgan

- TipRanks. All rights reserved.

Tue, 31 May 2022 11:45 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Cooper Co (COO) and Verrica Pharmaceuticals (VRCA)

- TipRanks. All rights reserved.

Fri, 08 Apr 2022 09:35 GMT Cooper Co (COO) Initiated with a Hold at Needham

- TipRanks. All rights reserved.

Fri, 04 Mar 2022 12:10 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Cooper Co (COO), Cytokinetics (CYTK) and Singular Genomics Systems (OMIC)

- TipRanks. All rights reserved.

Fri, 04 Mar 2022 11:47 GMT Cooper Posts Better-Than-Expected Q1 Results

- TipRanks. All rights reserved.

Fri, 18 Feb 2022 14:20 GMT The Cooper Companies: Strong Results, Attractive Valuation

- TipRanks. All rights reserved.

Tue, 11 Jan 2022 09:29 GMT Rivians 2021 Production Misses Estimates, COO Steps Down Report

- TipRanks. All rights reserved.

News

Stocktwits